Literature DB >> 2484434

Antiphosphotyrosine antibodies modulate insulin receptor kinase activity and insulin action.

R Ballotti1, J C Scimeca, A Kowalski, E Van Obberghen.   

Abstract

Insulin elicits the autophosphorylation of the beta-subunit of its receptor on tyrosine residues: this effect appears to be the earliest post-binding event involved in insulin action. In the present study we have raised highly specific antibodies to phosphotyrosine residues, and we have taken advantage of these antibodies to further evaluate the role of the insulin receptor tyrosine kinase in the generation of insulin's biological responses. Using a cell-free phosphorylation assay, we show here that these antibodies increase the tyrosine kinase activity of the receptor, and its phosphorylation on tyrosine residues. In contrast, the antibodies do not interfere with dephosphorylation of the insulin receptor. Introduction of the same antibodies in living Fao hepatoma cells enhances the effect of insulin on both glucose transport and aminoacid uptake. As a whole our data indicate that the insulin receptor kinase is involved in the generation of an early (glucose transport) and late (aminoacid uptake) response to insulin. Further, conformational changes in phosphotyrosine containing domains of the insulin receptor appear to modulate insulin's biological effects. Finally, the injection of antibodies in intact cells provides us with a novel and promising tool to search for cellular substrates for the insulin receptor tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2484434     DOI: 10.1016/0898-6568(89)90010-7

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

1.  Antibodies to insulin receptor tyrosine kinase stimulate its activity towards exogenous substrates without inducing receptor autophosphorylation.

Authors:  V Baron; N Gautier; N Rochet; R Ballotti; B Rossi; S Saint-Pierre; E Van Obberghen; J Dolais-Kitabgi
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

2.  Insulin and insulin-like-growth-factor-I (IGF-I) receptors in Xenopus laevis oocytes. Comparison with insulin receptors from liver and muscle.

Authors:  P Hainaut; A Kowalski; S Giorgetti; V Baron; E Van Obberghen
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

3.  Insulin and orthovanadate stimulate multiple phosphotyrosine-containing serine kinases.

Authors:  J C Scimeca; R Ballotti; C Filloux; E Van Obberghen
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

4.  Dephosphorylation of human insulin-like growth factor I (IGF-I) receptors by membrane-associated tyrosine phosphatases.

Authors:  P Peraldi; S Hauguel-de Mouzon; F Alengrin; E Van Obberghen
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

5.  Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice.

Authors:  S J Heydrick; D Jullien; N Gautier; J F Tanti; S Giorgetti; E Van Obberghen; Y Le Marchand-Brustel
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae.

Authors:  R Ballotti; R Lammers; J C Scimeca; T Dull; J Schlessinger; A Ullrich; E Van Obberghen
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

7.  Activation of insulin-epidermal growth factor (EGF) receptor chimerae regulates EGF receptor binding affinity.

Authors:  S Tartare; R Ballotti; R Lammers; C Filloux; A Chauvel; J Schlessinger; A Ullrich; E Van Obberghen
Journal:  J Cell Biol       Date:  1992-02       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.